223 related articles for article (PubMed ID: 33061308)
1. Integrated Network Pharmacology Analysis and Pharmacological Evaluation to Explore the Active Components and Mechanism of
Gu L; Hong F; Fan K; Zhao L; Zhang C; Yu B; Chai C
Drug Des Devel Ther; 2020; 14():4053-4067. PubMed ID: 33061308
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms and effects of Abelmoschus manihot preparations in treating chronic kidney disease].
Chen P; Wan Y; Wang C; Zhao Q; Wei Q; Tu Y; Yin X
Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2252-6. PubMed ID: 23189729
[TBL] [Abstract][Full Text] [Related]
3. Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of Abelmoschus manihot flowers in treatment of kidney diseases.
Li N; Tang H; Wu L; Ge H; Wang Y; Yu H; Zhang X; Ma J; Gu HF
Phytother Res; 2021 Jan; 35(1):198-206. PubMed ID: 32716080
[TBL] [Abstract][Full Text] [Related]
4. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
Ge J; Miao JJ; Sun XY; Yu JY
J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
[TBL] [Abstract][Full Text] [Related]
5. Renal protective effect and action mechanism of Huangkui capsule and its main five flavonoids.
Cai HD; Su SL; Qian DW; Guo S; Tao WW; Cong XD; Tang R; Duan JA
J Ethnopharmacol; 2017 Jul; 206():152-159. PubMed ID: 28408246
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis of comprehensive metabolomics and network pharmacology to reveal the mechanisms of
Liao JC; Li CY; Teng FM; Jian-Chen ; Yu JY; Ju WZ; Zou JD
Front Pharmacol; 2022; 13():1064498. PubMed ID: 36467079
[No Abstract] [Full Text] [Related]
7. Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation.
Qin T; Wu L; Hua Q; Song Z; Pan Y; Liu T
J Ethnopharmacol; 2020 Jan; 246():112128. PubMed ID: 31386888
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profiles of the Flos Abelmoschus manihot extract by intestinal bacteria from the normal and CKD model rats based on UPLC-Q-TOF/MS.
Du LY; Tao JH; Jiang S; Qian DW; Guo JM; Duan JA
Biomed Chromatogr; 2017 Feb; 31(2):. PubMed ID: 27451133
[TBL] [Abstract][Full Text] [Related]
9. A single-cell profile reveals the transcriptional regulation responded for Abelmoschus manihot (L.) treatment in diabetic kidney disease.
Wu C; Tang H; Cui X; Li N; Fei J; Ge H; Wu L; Wu J; Gu HF
Phytomedicine; 2024 Jul; 130():155642. PubMed ID: 38759315
[TBL] [Abstract][Full Text] [Related]
10. The pharmacological mechanism of
Wei C; Wang C; Li R; Bai Y; Wang X; Fang Q; Chen X; Li P
Heliyon; 2023 Nov; 9(11):e22017. PubMed ID: 38058638
[No Abstract] [Full Text] [Related]
11. Yishen Qingli Heluo Granule in the Treatment of Chronic Kidney Disease: Network Pharmacology Analysis and Experimental Validation.
Sun X; Huang Y; Zhu S; Yan J; Gan K; Xu Z; Wang S; Kang X; Zhang J; Sun W
Drug Des Devel Ther; 2022; 16():769-787. PubMed ID: 35355655
[TBL] [Abstract][Full Text] [Related]
12. [Antidepressant activity of flavonoid ethanol extract of Abelmoschus manihot corolla with BDNF up-regulation in the hippocampus].
Cai HD; Tao WW; Su SL; Guo S; Zhu Y; Guo JM; Qian DW; Cong XD; Tang RM; Duan JA
Yao Xue Xue Bao; 2017 Feb; 52(2):222-8. PubMed ID: 29979503
[TBL] [Abstract][Full Text] [Related]
13. Total flavone of
Yang BL; Zhu P; Li YR; Xu MM; Wang H; Qiao LC; Xu HX; Chen HJ
World J Gastroenterol; 2018 Aug; 24(30):3414-3425. PubMed ID: 30122880
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial.
Zhang L; Li P; Xing CY; Zhao JY; He YN; Wang JQ; Wu XF; Liu ZS; Zhang AP; Lin HL; Ding XQ; Yin AP; Yuan FH; Fu P; Hao L; Miao LN; Xie RJ; Wang R; Zhou CH; Guan GJ; Hu Z; Lin S; Chang M; Zhang M; He LQ; Mei CL; Wang L; Chen X
Am J Kidney Dis; 2014 Jul; 64(1):57-65. PubMed ID: 24631042
[TBL] [Abstract][Full Text] [Related]
15. Anticonvulsant, antidepressant-like activity of Abelmoschus manihot ethanol extract and its potential active components in vivo.
Guo J; Xue C; Duan JA; Qian D; Tang Y; You Y
Phytomedicine; 2011 Nov; 18(14):1250-4. PubMed ID: 21784623
[TBL] [Abstract][Full Text] [Related]
16. HUANGKUISIWUFANG inhibits pyruvate dehydrogenase to improve glomerular injury in anti-Thy1 nephritis model.
Lu T; Bian Y; Zhu Y; Guo M; Yang Y; Guo J; Gu C; Duan JA
J Ethnopharmacol; 2020 May; 253():112682. PubMed ID: 32087318
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of the Bupi Yishen formula on renal fibrosis through PI3K/AKT signaling inhibition.
Liu B; Deng J; Jie X; Lu F; Liu X; Zhang D
J Ethnopharmacol; 2022 Jul; 293():115242. PubMed ID: 35367329
[TBL] [Abstract][Full Text] [Related]
18. Shenqi detoxification granule combined with P311 inhibits epithelial-mesenchymal transition in renal fibrosis via TGF-β1-Smad-ILK pathway.
Cai P; Liu X; Xu Y; Qi F; Si G
Biosci Trends; 2017; 11(6):640-650. PubMed ID: 29311449
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of
Xu Z; Qian L; Niu R; Wang Y; Yang Y; Liu C; Lin X
Front Nephrol; 2022; 2():834513. PubMed ID: 37675022
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Gegen Qinlian Pill to ameliorate irinotecan-induced diarrhea investigated by the combination of serum pharmacochemistry and network pharmacology.
Wu Y; Cheng Y; Yang Y; Wang D; Yang X; Fu C; Zhang J; Hu Y
J Ethnopharmacol; 2021 Aug; 276():114200. PubMed ID: 33989737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
